Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Applications to this course for the 2023/24 academic year have now closed. You can see a selection of the projects which were available for the 2023/24 admissions round listed below, and you can find out more information about these by clicking on the title on the menu to the left. 

These projects just provide an indication of the type of work that is conducted in the Department  of Oncology. A new list of projects will be provided here when the applications open for 2024/25. 

  • Investigating the role of E3 ubiquitin ligases in cancer pathogenesis
  • P97-UFD1-LARP1 axis regulates autophagy and PARP inhibitor resistance in ovarian cancer
  • Nucleases and helicases as potential cancer targets
  • Characterisation of DNA-protein crosslink proteolysis repair in response to chemotherapy
  • The role of MAFF-mediated redox system in tumour and immune responses
  • Discovery of new drugs for CRC prevention by targeting the BMP pathway
  • Hypermutation as a driving force for cancer: can there be too much of a good thing?
  • Investigation into the dynamics of DNA damage and repair of cells following FLASH and conventional irradiation
  • Molecular mechanisms of mitotic DNA synthesis in BRCA2-deficient cells